Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Teachey

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
F1000Research|November 11, 2017
Autoimmune lymphoproliferative syndrome: more than a FAScinating diseaseKaren Bride, David Teachey
Hematology. American Society of Hematology. Education Program|December 5, 2025
The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy eraSumit Gupta, Jennifer McNeer, Maureen O'Brien, et al.
Cancer Research|October 19, 2007
Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signalingValerie I Brown, Jessica Hulitt, Jonathan Fish, et al.
Haematologica|February 17, 2018
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemiaNikki A Evensen, P Pallavi Madhusoodhan, Julia Meyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Contemporary Clinical Trials|October 13, 2022
Design and methods of a randomized web-based physical activity intervention among children with cancer: A report from the Children's Oncology GroupMegan E Ware, Nina S Kadan-Lottick, Meenakshi Devidas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyHiroto Inaba, David Teachey, Colleen Annesley, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
F1000Research|November 11, 2017
Autoimmune lymphoproliferative syndrome: more than a FAScinating diseaseKaren Bride, David Teachey
Hematology. American Society of Hematology. Education Program|December 5, 2025
The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy eraSumit Gupta, Jennifer McNeer, Maureen O'Brien, et al.
Cancer Research|October 19, 2007
Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signalingValerie I Brown, Jessica Hulitt, Jonathan Fish, et al.
Haematologica|February 17, 2018
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemiaNikki A Evensen, P Pallavi Madhusoodhan, Julia Meyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Contemporary Clinical Trials|October 13, 2022
Design and methods of a randomized web-based physical activity intervention among children with cancer: A report from the Children's Oncology GroupMegan E Ware, Nina S Kadan-Lottick, Meenakshi Devidas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyHiroto Inaba, David Teachey, Colleen Annesley, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
Pageof 2